Graylight Innovations completes acquisition of Graylight Imaging  

We are pleased to officially announce the news that has been circulating in the media for the past few days. At the beginning of September, Graylight Innovations acquired a majority stake in our company. Thanks to this venture, we will be able to devote even more effort to research and development aimed at improving cardiac diagnostic methods based on heart CT scans.  

Graylight Innovations completed a strategic acquisition of 90% of Graylight Imaging (former Future Processing Healthcare) on September 3, 2024, marking a significant milestone for both companies. The remaining 10% of the shares will be held by Future Processing S.A., ensuring operational continuity and allowing the previous owner to share in future successes.  

The technology currently being developed by Graylight Imaging offers a promising solution to the global burden of cardiovascular disease, by enabling earlier detection, more accurate diagnosis, and improved treatment. This strategic move unites advanced AI technologies with deep expertise in medical imaging, enabling the delivery of highly accurate diagnostic tools to healthcare professionals.  

“The acquisition of a substantial stake in Graylight Imaging (former Future Processing Healthcare) by Graylight Innovations marks a groundbreaking moment for the medical industry. Thanks to the synergy of key competencies in artificial intelligence and medical imaging, we are able to provide even more precise diagnostic tools that will revolutionize cardiology and, above all, allow for very early detection of atherosclerotic changes, ultimately preventing cardiovascular disease — the leading cause of death in Poland, responsible for 160,000 deaths annually,” said Professor Maciej Banach, professor of preventive cardiology and lipidology, and co-owner of Graylight Imaging.  

The new owners of Graylight Imaging are: Aniela Hejnowska, an expert in managing organizations in the e-commerce, health, and new technology sectors; Professor Maciej Banach, a renowned cardiologist, researcher, chair of the International Lipid Expert Panel, Vice-Rector of the John Paul II Catholic University of Lublin and academic lecturer at the Medical University of Lodz and Johns Hopkins University in Baltimore; and Dr. Eng. Jarosław Bułka, an expert in AI, digital transformation, and telemedicine. They are joined by Szymon Janota, long-time CEO of Graylight Imaging, and Ewa Kieczka-Baranowska, the former Head of Business and People at the same company, both with over a decade of experience in the IT industry.   

Simultaneously with the change in ownership, the company is launching an unprecedented employee stock option program in Poland, granting the entire current Graylight Imaging team the opportunity to become co-owners. The knowledge and experience of the ownership team, combined with the existing team of experts in computer science, medicine, and physics, create a unique environment for the development of innovative solutions in the healthcare sector, with a particular focus on cardiology.  

Prof. Maciej Banach is a Vice-Rector for the Collegium Medicum in the John Paul II Catholic University of Lublin (KUL) and Head of Department of Preventive Cardiology and Lipidology at the Medical University of Lodz (MUL).

He is also an Adjunct Professor at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, and Senior Research Fellow at the Liverpool Centre for Cardiovascular Sciences (LCCS).

He is a Founder and Head of the Polish Lipid Association (PoLA), Founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, and President of the International Lipid Expert Panel (ILEP).

Prof. Banach has published >1500 original papers in the field of dyslipidemia, atherosclerosis, preventive cardiology, and risk stratification (citations: 97,354, IH=105 acc. Web of Science Core Collection, 164,427, IH=138 acc. Google Scholar) – being within 1% the highest cited scientists in the world according to Essential Science Indicators by Clarivate (with 66 TOP Papers) and the most cited scientists in Poland for the last 5 years (based on the InCites by Clarivate).

He is a laureate of several prizes and award, including: the Most Influential Person in Medicine in Poland for year 2023 on the Top 100 list by Puls Medycyny journal (2024), and 5 recognitions of Doctor Honoris Causa (at the Universities in Zagreb, Kosice, Bucharest, Kiev, and Timișoara). 

Jarosław Bułka, a biocyberneticist with 20 years of academic experience in the Department of Automation and Biomedical Engineering at AGH University of Science and Technology. Author of over 50 publications in the fields of artificial intelligence, neural networks, telemedicine, telediagnosis, and biomedical engineering. Jarosław Bułka focuses on telemedicine, telecare, data analysis, artificial intelligence, digital transformation of organizations, and process optimization.

He is a co-organizer of numerous industry conferences, a panelist, and a popularizer of research and development activities as well as knowledge transfer from science to business. He has organized and implemented many innovative R&D projects. He is the Secretary of the Accreditation Commission of Technical Universities and a member of the Małopolska Information Society Council under the Marshal of the Małopolska Region. Jarosław Bułka is also a co-founder (since 2002) and until 2018 a member of the board in the Silvermedia capital group companies. Between 2021 and 2023, he served as the Chief Digital Officer at Diagnostyka S.A. and was a juror in the Digital Excellence Award – CIONET. He is the initiator of the Tech4KRK project, an initiative that integrates Krakow-based businesses around projects implemented for the city authorities and residents of Krakow. He is the owner of SOPHILUTION and the CEO of MedDataSolution sp. z o.o., a company that deals with the analysis of diagnostic data and the use of analysis results in the pharmaceutical business. He is a member of the Council of the Krakow Institute of Technology – the Łukasiewicz Network and also the plenipotentiary of the Mayor of Krakow for Digital Transformation.

Aniela Hejnowska – Member of the Supervisory Boards and investor. Since June 2023, she has held the roles of independent member of the Supervisory Board and Chair of the Audit Committee of Benefit Systems S.A. and member of the Supervisory Board and Audit Committee of Murapol S.A. From 2020 to 2023, she served as GM of IQVIA, a global leader in healthcare consulting, research, technology and data analytics. Aniela moved from the role of Chief Operating Officer, a member of the Board of Directors of Microsoft in Poland. She has more than 18 years of experience in managing organizations in the telecommunications and new technology sectors.

Aniela specializes in GTM strategy, technology and organizational culture transformations. She was awarded, among others, the Businesswoman of the Year 2010 title by the Sukces Pisany Szminką Foundation promoting professional and personal development of women. She is actively involved in social initiatives by serving on the advisory boards of the Businesswomen Leaders Foundation and the Cosmos for Girls Foundation. She graduated with honors from the Ecole Superieure de Commerce in Grenoble.  

In addition to her corporate experience, Aniela is an entrepreneur, having co-founded Renters.co.uk, which was bought by EI in 2023. She is co-founder of Graylight Innovations, developing AI-based diagnostic software, and Termostars, active in the field of renewable energy. Privately, she is a curious reader, traveller, mother and lover of art and sports.

Graylight Imaging specializes in developing medical software based on artificial intelligence (AI) and machine learning (ML) that enables more accurate and faster analysis of medical images. The company’s flagship product is an innovative technology designed for analyzing heart computed tomography images. Why is this solution so important in cardiology? Firstly, it will allow for early warning of threats. Imagine having a tool that can detect the first signs of a disease before it fully develops and presents any symptoms. This is exactly what Graylight Imaging technology offers. Thanks to advanced artificial intelligence, it will be able to detect even the smallest changes in arteries, enabling early investment in health and effective treatment.  

“In a world where heart disease remains the leading health threat, Graylight Imaging technology emerges as a groundbreaking solution. It is not merely software; it is an intelligent partner for cardiologists, revolutionizing the way we diagnose and treat heart disease,” emphasizes Professor Maciej Banach.  

Graylight Imaging is more than just a technology company. The team’s work is regularly featured in top scientific journals and at international conferences.  

“Our team consists of top-tier specialists and passionate individuals who combine expertise in medicine, bioengineering, computer science, and artificial intelligence. This enables us to create innovative diagnostic tools that set new standards in cardiology. Our commitment to scientific research drives the continuous development of our products and allows us to offer patients the best possible care. Additionally, as a globally oriented company, we collaborate with leaders in the medical market worldwide. This allows us to leverage the latest scientific advancements and incorporate them into our products,” emphasizes Ewa Kieczka-Baranowska, co-owner of Graylight Imaging.  

“Our research is funded by both internal resources and research grants, enabling us to undertake ambitious projects. These projects allow us not only to improve existing solutions but also to create entirely new products. Our research contributes to the advancement of medicine and improves the quality of life for patients worldwide. We are convinced that through our collaborative efforts, we can build a healthier future for all,” concludes Aniela Hejnowska.

Welcome, Aniela, Jarek, and Maciej aboard! We can’t wait for this amazing adventure together.